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As continuous bioprocessing rapidly approaches the opportunity to add to the global drug supply, establishing a 
robust continuous viral inactivation (CVI) step and associated validation testing is paramount.  The use of a plug 
flow reactor possesses significant advantages over a multiple tank system in that the product spends less time 
low pH conditions; it provides the ability to sanitize between cycles; lacks air-liquid interfaces; and enables the 
1-point standardization of the pH probe that provides the assurance of reaching the desired target pH.  A critical 
parameter that poses a perceived new challenge is the definition of the exact incubation time of the product 
stream at production scale, as dispersion effects need to be accounted. Through extensive residence time 
distribution experimentation, the impact of viscosity, flow rate, and CVI reactor scaling parameters, flow 
characteristics were identified. This allowed the elucidation of the flow mechanics regarding the transition to 
weak turbulence inside the reactor due to Dean vortices. Leveraging the Dean vortices influence on dispersion, 
residence time for the product stream could be calculated allowing for the identification of worst case conditions 
(i.e. maximum and minimum residence time). The ultimate goal is to use the minimum residence time as the 
target inactivation time that will allow for a simplified batch based validation strategy in which the worst case 
conditions for a continuous viral inactivation step could be captured and quantified in a test tube, and be 
representative of the continuously operated system. 
 
